Benga Kazeem, PhD, CStat

Director of Statistics
GSK, Stevenage, United Kingdom, United Kingdom

Poster(s):

• (306) Life-year and quality-adjusted life-year results from a United States cost-effectiveness model for belantamab mafodotin, bortezomib, and dexamethasone in relapsed/refractory multiple myeloma
  Wednesday, October 29, 2025